Agarikon Conk As A Potential Smallpox Remedy – NPR Interview With Paul Stamets
In a fascinating broadcast on National Public Radio, internationally renowned medicinal mushroom expert Paul Stamets tells his story of discovering the medicinal potential of agarikon, an extremely rare and threatened species of wood conk that requires century-old trees to grow. Agarikon is today all but extinct in Europe, its remaining distribution limited to the old growth forests on the North American West Coast.
Knowing that mushrooms are susceptible to many of the same microbes as humans, how could it be, he asked himself, that this perennial wood conk managed to stay healthy for 50 years in the dripping wet rain forest without rotting? It must have a powerful immune system, he concluded, with potentially powerful medicinal compounds that could benefit humans.
To find agarikon in the wild, look for something reminiscent of a beehive on the ancient tree trunks of an old-growth forest. (You may view a picture of agarikon through the agarikon-link on this page.) Please keep in mind that agarikon is a rare and threatened species. Do not harvest it unless there’s a very good reason for doing so. But by all means, bring out your digital camera.
It should be noted that the agarikon Paul Stamets uses is not harvested in the wild. He grows his own, and uses it for the extract he produces. A sample of that extract was submitted to the Defense Department, to be tested at a top security laboratory in Fort Dietrich, Maryland. The Defense Department’s BIO Shield Program at that location searches for cures to biological warfare agents such as smallpox and anthrax.
Reportedly, tens of thousands of natural as well as manmade remedies are tested through the BIO Shield Program. According to drug discovery supervisor John Seacrest, Paul Stamets agarikon extract scored one of the rare hits against viruses related to smallpox. In other words, it effectively inhibited smallpox related viruses under lab conditions.
In lieu of this discovery, Stamets has applied for a patent to a mushroom related anti-viral drug. One of his sponsors is Boston investor John Norris. As Mr. Norris so correctly points out, not everybody is willing or able to be vaccinated.
It’s also worth mentioning that Mr. Norris is a former second in command in the FDA hierarchy, and he believes that through his joint venture with Paul Stamets, they could soon be selling several hundred million doses of the Stamets agarikon extract to the armies of the United States, U.K., and Germany.
That may, however, still be a few years in the making. First the product needs to go through further exhaustive lab trials as well as gain FDA approval.
Note: The above article is intended for informational purposes only. Agarikon has not been approved by the FDA for use as a medicinal. Never use any herbal or mushroom-product for medicinal purposes unless advice to do so by a licensed medical practitioner.
Reference: Banse, T., NPR Morning Edition, Smallpox Defense May Be Found in Mushrooms, August 4, 2005.
About author: Dr. Markho Rafael has worked with natural health products since the mid-90′s, specializing in mycomedicinals. Click Agarikon Mushrooms for agarikon-photo, mushroom products, free mushroom articles, or to request a unique copy of any mushroom article for your own web-site or magazine / ezine. Click Fomitopsis medicinal for scientific research references about agarikon.
Incoming search terms for the article:
